PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom.\', \'Department of Immunology, North Bristol NHS Trust, Bristol, United Kingdom.\', \'Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, United Kingdom.\', \'Bristol Centre for Antimicrobial Research (BCARE), North Bristol NHS Trust, Bristol, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0249607
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33914762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all